INS and obesity disorder: In terms of obesity and metabolic syndrome, a fair number of the trials showed that fecal microbiome transplantation did not affect clinical parameters, including BMI, even though it partially improved peripheral insulin sensitivity, suggesting that a short duration of the intervention should be considered (98).